Purchase Order HHSP284201500116A
Award Date 5/15/15
Potential Completion Date 6/17/15
Potential Value $2.6M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. government agency, the Medical Supply Chain, has awarded a $1,400.00 firm fixed price delivery order contract to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. This contract has no set-aside designation and the performance will take place at Glaxosmithkline's facilities in Durham, North Carolina. Glaxosmithkline has also received several other federal contracts and grants to supply a range of pharmaceutical products and services, including...
- The Department of Health and Human Services awarded a $121,391.84 firm fixed-price delivery order to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of vaccines. This award is part of a larger General Services Administration Federal Supply Schedule 61 contract for pharmaceuticals and drugs. The contract does not have a set-aside designation and the place of performance is Glaxosmithkline's facility in Research Triangle Park, North Carolina. Glaxosmithkline is a major supplier...
- This is a firm fixed-price delivery order awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antivirals, and other pharmaceutical products to U.S. government agencies. The $15,769,590.00 contract is for commercial bulk lots, with no set-aside designation, and is part of the Pandemic Influenza Preparedness and Response 2016-2021 IDIQ contract. The...
- This contract was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Administration to the prime contractor Glaxosmithkline, LLC, a foreign-owned for-profit pharmaceutical company, to provide vaccines for the government's stock. The $172,923.02 firm fixed price delivery order was issued under Glaxosmithkline's Federal Supply Schedule 61-IB contract for pharmaceuticals and drugs. The award does not have a set-aside designation. Glaxosmithkline is a...
- This $563,504 firm fixed price delivery order was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The order is part of the Pandemic Influenza Preparedness and Response 2016-2021 indefinite delivery, indefinite quantity (IDIQ) contract and does not have a...
- This federal contract award for $2,408,448.00 was issued by the Medical Supply Chain division of the U.S. Department of Defense to the pharmaceutical company Glaxosmithkline, LLC for the delivery of influenza virus vaccines. The contract is a firm fixed price delivery order with no set-aside designation, and performance will occur at Glaxosmithkline's facilities in North Carolina. This award is part of a larger indefinite delivery vehicle (IDV) contract held by Glaxosmithkline to provide a range...
- This federal contract award was issued by the Department of Health and Human Services Office of the Assistant Secretary for Administration to Glaxosmithkline, LLC, doing business as Glaxosmithkline, a pharmaceutical company that supplies vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The $166,571.80 firm fixed price delivery order is for the provision of vaccines, with no set-aside designation. It is associated with Glaxosmithkline's General...
- This is a firm fixed price delivery order award to Glaxosmithkline, LLC, doing business as Glaxosmithkline, by the U.S. Department of Health and Human Services Office of the Assistant Secretary for Administration. The $157,037.17 award is for the provision of vaccines to support federal immunization programs. The contract was issued under Glaxosmithkline's existing General Services Administration Federal Supply Schedule contract for pharmaceuticals and drugs, with no set-aside designation....
- This is a firm fixed price delivery order awarded by the Department of Veterans Affairs Veterans Health Administration (VA/VHA) to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of flu vaccines for fiscal year 2019. The potential value of the order is $142,272.00. The order has no set-aside designation and the place of performance is Research Triangle Park, North Carolina. Glaxosmithkline has provided a range of pharmaceutical products and services to U.S. government...
- This federal contract award was issued by the Medical Supply Chain division of the U.S. Department of Defense to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. The firm fixed price delivery order, valued at $29,850, has an ultimate completion date of October 19, 2018. The contract was not set aside for any socioeconomic category. Glaxosmithkline, LLC has also received multiple award indefinite delivery vehicles from the Centers for Disease...